A functional polymorphism in the SULT1A1 gene (G638A) is associated with risk of lung cancer in relation to tobacco smoking

Carcinogenesis

Volumn 25, Issue 5, 2004, Pages 773-778

  Liang, Gang ^a   Miao, Xiaoping ^a   Zhou, Yifeng ^a   Tan, Wen ^a   Lin, Dongxin ^a  

^a CANCER HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ADENINE; GUANINE; SULFOTRANSFERASE; SULFOTRANSFERASE 1A1; UNCLASSIFIED DRUG;

ADULT; AGED; ALLELE; ARTICLE; CANCER PREVENTION; CANCER RISK; CASE CONTROL STUDY; CONFIDENCE INTERVAL; CONTROLLED STUDY; FEMALE; GENE FUNCTION; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LUNG ADENOCARCINOMA; LUNG CANCER; LUNG CARCINOGENESIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING; SQUAMOUS CELL CARCINOMA; STRATIFICATION;

ADENOCARCINOMA; ADULT; AGED; CARCINOMA, SQUAMOUS CELL; CASE-CONTROL STUDIES; FEMALE; GENE FREQUENCY; GENOTYPE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; ODDS RATIO; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS; SMOKING;

EID: 2442537027     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/bgh053     Document Type: Article

References (50)

1. Yang,L., Parkin,D.M., Li,L. and Chen,Y. (2003) Time trend in cancer mortality in China: 1987-1999. Int. J. Cancer, 106, 771-783.
2. Chen,Z.M, Xu,Z., Collis,R., Li,W.Y. and Peto,R. (1997) Early health effects of the emerging tobacco epidemic in China. A 16-years prospective study. J. Am. Med. Assoc., 278, 1500-1504.
3. Peto,R., Lopez,A.D., Boreham,J., Thun,M., Heath,C.,Jr and Doll,R. (1996) Mortality from smoking worldwide. Br. Med. Bull., 52, 12-21.
4. Kleinerman,R., Wang,Z., Lubin,J., Zhang,S., Metayer,C. and Brenner,A. (2000) Lung cancer and indoor air pollution in rural China. Ann. Epidemiol., 10, 469.
5. Metayer,C., Wang,Z., Kleinerman,R.A., Wang,L., Brenner,A.V., Cui,H., Cao,J. and Lubin,H. (2002) Cooking oil fumes and risk of lung cancer in women in rural Gansu, China. Lung Cancer, 35, 111-117.
6. Seow,A., Poh,W.T., The,M., Eng,P., Wang,Y.T., Tan,W.C., Yu,M.C. and Lee,H.P. (2000) Fumes from meat cooking and lung cancer risk in Chinese women. Cancer Epidemiol. Biomarkers Prev., 9, 1215-1221.
7. Hecht,S.S. (2002) Cigarette smoking and lung cancer: chemical mechanisms and approaches to prevention. Lancet Oncol., 3, 461-469.
8. Autrup,H. (2000) Genetic polymorphisms in human xenobiotica metabolizing enzymes as susceptibility factors in toxic response. Mutat. Res., 464, 65-76
9. Bartsch,H., Nair,U., Risch,A., Rojas,M., Wilman,H. and Alexandov,K. (2000) Genetic polymorphism of CYP genes, alone or in combination, as a risk modifier of tobacco-related cancers. Cancer Epidemiol. Biomarkers Prev., 9, 3-28.
10. Houlston,R.S. (1999) Glutathione S-transferase M1 status and lung cancer risk: a meta-analysis. Cancer Epidemiol. Biomarkers Prev., 8, 675-682.
11. Lan,Q., He,X., Costa,D.J., Tian,L., Rothman,N., Hu,G. and Muford,J.L. (2000) Indoor coal combustion emissions, GSTM1 and GSTT1 genotypes, and lung cancer risk: a case-control study in Xuan Wei, China. Cancer Epidemiol. Biomarkers Prev., 9, 605-608.
12. Whyatt,R.M., Bell,D.A., Jedrychowski,W. et al. (1998) Polycyclic aromatic hydrocarbon-DNA adducts in human placenta and modulation by CYP1A1 induction and genotype. Carcinogenesis, 19, 1389-1392.
13. Nebert,D.W., Magnus,I.S. and Daly,A.K. (1999) Genetic epidemiology of environmental toxicity and cancer susceptibility: human allelic polymorphisms in drug-metabolizing genes, their functional importance, and nomenclature issues. Drug Metab. Rev., 31, 467-487.
14. Falany,C.N. (1997) Enzymology of human cytosolic sulfotransferases. FASEB J., 11, 206-216.
15. Coughtrie,M.W., Sharp,S., Maxwell,K. and Innes,N.P. (1998) Biology and function of the reversible sulfation pathway catalysed by human sulfotransferases and sulfatases. Chem.-Biol. Interact., 109, 3-27.
16. Banoglu,E. (2000) Current status of the cytosolic sulfotransferases in the metabolic activation of promutagens and procarcinogens. Curr. Drug Metab., 1, 1-30.
17. Coughtrie,M.W.H. (1996) Sulphation catalysed by the human cytosolic sulphotransferases-chemical defence or molecular terrorism? Hum. Exp. Toxicol., 15, 547-555.
18. Ozawa,S., Chou,H.C., Kadlubar,F.F., Nagata,K., Yamazoe,Y. and Kato,R. (1994) Activation of 2-hydroxyamino-1-methyl-6-phenylimidazo[4,5-b]pyridine by cDNA-expressed human and rat arylsulfotransferases. Jpn. J. Cancer Res., 85, 1220-1228.
19. Chou,H.C., Lang,N.P. and Kadlubar,F.F. (1995) Metabolic activation of the N-hydroxy derivative of the carcinogen 4-aminobiphenyl by human tissue sulfotransferases. Carcinogenesis, 16, 413-417.
20. Watable,T., Ishizuka,T., Isobe,M. and Ozawa,N. (1982) A 7-hydroxymethyl sulfate ester as an active metabolite of 7,12-dimethylbenzo[a]-anthracene. Science, 215, 403-405.
21. Surh,Y.J. and Tannenbaum,S.R. (1995) Sulfotransferase-mediated activation of 7, 8, 9, 10-tetrahydro-7-ol, 7, 8-dihydrodiol, and 7, 8, 9, 10-tetraol derivatives of benzo[a]pyrene. Chem. Res. Toxicol., 8, 693-698.
22. Arlt,V.M., Glatt,H., Muckel,E., Pabel,U., Sorg,B.L., Schmeiser,H.H. and Phillips,D.H. (2002) Metabolic activation of the environmental contaminant 23-nitrobenzanthrone by human acetyltransferases and sulfotransferase. Carcinogenesis, 23, 1937-1945.
23. Willey,J.C., Coy,E., Brolly,C., Utell,M.J, Frampton,M.W., Hammersley,J., Thilly,W.C., Olson,D. and Cairns,K. (1996) Xenobiotic metabolism enzyme gene expression in human bronchial epithelial and alveolar macrophage cells. Am. J. Respir. Cell Mol. Biol., 14, 267-272.
24. Vietri,M., Pietrabissa,A., Mosca,F., Spisni,R. and Pacifici,G.M. (2003) Curcumin is a potent inhibitor of phenol sulfotransferase (SULT1A1) in human liver and extrahepatic tissues. Xenobiotica, 33, 357-363.
25. Song,W.C., Qian,Y. and Li,A.P. (1998) Estrogen sulfotransferase expression in the human liver: marked interindividual variation and lack of gender specificity. J. Pharmacol. Exp. Ther., 284, 1197-1202.
26. Price,R.A., Spielman,R.S., Lucena,A.L., Van Loon,J.A., Maidak,B.L. and Weinshilboum,R.M. (1989) Genetic polymorphism for human platelet thermostable phenol sulfotransferase (TS PST) activity. Genetics, 122, 905-914
27. Raftogianis,R.B., Wood,T.C., Otterness,D.M., Van Loon,J.A. and Weinshilboum,R.M. (1997) Phenol sulfotransferase pharmacogenetics in humans: association of common SULT1A1 alleles with TS PST phenotype. Biochem. Biophys. Res. Commun., 239, 398-304.
28. Adjei,A.A., Prondzinski,J.E, Olson,J.E., Vierkant,R.A., Pankratz,V.S., Fredericksen,Z.S., Sellers,T.A. and Weinshilboum,R.M. (2003) SULT1A1 5′-flanking region polymorphisms and breast cancer risk in the Minesota Breast Cancer Family Study. Proc. Am. Assoc. Cancer Res., 44, 1249.
29. Ozawa,S., Tang,Y.M., Yamazoe,Y., Kato,R., Lang,N.P. and Kadlubar,F.F. (1998) Genetic polymorphisms in human liver phenol sulfotransferases involved in the bioactivation of N-hydroxy derivatives of carcinogenic arylamines and heterocyclic amines. Chem.-Biol. Interact., 109, 237-248.
30. Coughtrie,M.W.H., Gilissen,R.A.H.J., Shek,B., Strange,R.C., Fryer,A.A., Jones,P.W. and Bamber,D.E. (1999) Phenol sulfotransferase SULT1A1 polymorphism: molecular diagnosis and allele frequencies in Caucasian and African populations. Biochem. J., 337, 45-49.
31. Carlini,E.J., Raftogianis,R.B., Wood,T.C., Jin,F., Zheng,W., Rebbeck,T.R. and Weinshilboum,R.M. (2001) Sulfation pharmacogenetics: SULT1A1 and SULT1A2 allele frequencies in Caucasian, Chinese and African-American subjects. Pharmacogenetics, 11, 57-68.
32. 213His), both of which exist in Japanese as well Caucasians. J. Biochem., 126, 271-277.
33. Nowell,S., Ambrosone,C.B., Ozawa,S., MacLeod,S.L., Mrackova,G., Williams,S., Plaxco,J., Kadlubar,F.F and Lang,N.P. (2000) Relationship of phenol sulfotransferase activity (SULT1A1) genotype to sulfotransferase phenotype in platelet cytosol. Pharmacogenetics, 10, 789-797.
34. Steiner,M., Bastian,M., Schulz,W.A., Pulte,T., Franke,K.H., Rohring,A., Wolff,J.M., Seiter,H. and Schuff-Werner,P. (2000) Phenol sulfotransferase SULT1A1 polymorphism in prostate cancer: lack of association. Arch. Toxicol., 74, 222-225.
35. Seth,P., Lunetta,K.L., Bell,D.W. et al. (2000) Phenol sulfotransferases: hormonal regulation, polymorphism, and age of onset of breast cancer. Cancer Res., 60, 6859-6863.
36. Zheng,W., Xie,D., Cerhan,J.R., Sellers,T.A., Wen,W. and Folsom,A.R. (2001) Sulfotransferase 1A1 polymorphism, endogenous estrogen exposure, well-done meat intake, and breast cancer risk. Cancer Epidemiol. Biomarkers Prev., 10, 89-94.
37. Bamber,D.E., Fryer,A.A., Strange,R.C., Elder,J.B., Deakin,M., Rajagopal,R., Fawole,A., Gilissen,R.A., Campbell,F.C. and Coughtrie,M.W.H. (2001) Phenol sulphotransferase SULT1A1*1 genotype is associated with reduced risk of colorectal cancer. Pharmacogenetics, 11, 679-685.
38. Wong,C.F., Liyou,N., Leggett,B., Young,J., Johnson,A. and McManus,M.E. (2002) Association of the SULT1A1 R213H polymorphism with colorectal cancer. Clin. Exp. Pharmacol. Physiol., 29, 754-758.
39. Ozawa,S., Katoh,T., Inatomi,H., Imai,H., Kuroda,Y., Ichiba,M. and Ohno,Y. (2002) Association of genotypes of carcinogen-activating enzymes, phenol sulfotransferase SULT1A1 (ST1A3) and arylamine N-acetyltransferase NAT2, with urothelial cancer in a Japanese population. Int. J. Cancer, 102, 418-421.
40. Wu,M.-T., Wang,Y.-T., Ho,C.-K., Wu,D.-C., Lee,Y.-C., Hsu,H.-K., Kao,E.-L. and Lee,J.-M. (2003) SULT1A1 polymorphism and esophageal cancer in males. Int. J. Cancer, 103, 101-104.
41. Tang,D., Rundle,A., Mooney,L., Cho,S., Schnabel,F., Estabrook,A., Kelly,A., Levine,R., Hibshoosh,H. and Perera,F. (2003) Sulfotransferase 1A1 (SULT1A1) polymorphism, PAH-DNA adduct levels in breast tissue and breast cancer risk in a case-control study. Breast Cancer Res. Treat., 78, 217-222.
42. Wang,Y., Spitz,M.R., Tsou,A.M.-H., Zhang,K., Makan,N. and Wu,X. (2002) Sulfotransferase (SULT) 1A1 polymorphism as a predisposition factor for lung cancer: a case-control analysis. Lung Cancer, 35, 137-142.
43. Saintot,M., Malaveille,C., Hautefeuille,A. and Gerber,M. (2003) Interactions between genetic polymorphism of cytochrome P450-1B1, sulfotransferase 1A1, catechol-O-methyltransferase and tobacco exposure in breast cancer risk. Int. J. Cancer, 107, 652-657.
44. Liang,G., Xing,D., Miao,X., Tan,W., Yu,C., Lu,W. and Lin,D. (2003) Sequence variations in the DNA repair gene XPD and risk of lung cancer in a Chinese population. Int. J. Cancer, 105, 669-673.
45. Kleinbaum,D.G., Kupper,L.L. and Morgenstern,H. (1982) Epidemiologic Research: Principles and Quantitative Methods. Lifetime Learning Publications, London.
46. Nichols,K.E., Malkin,D., Garber,J.E., Fraumeni,J.F.,Jr and Li,F.P. (2001) Germ-line p53 mutations predispose to a wide spectrum of early-onset cancer. Cancer Epidemiol. Biomarkers Prev., 10, 83-87.
47. Edwards,S.M., Kote-Jarai,Z., Meitz,J. et al. (2003) Two percent of men with early-onset prostate cancer harbor germline mutations in the BRCA2 gene. Am. J. Hum. Genet., 72, 1-12.
48. Denissenko,M.F., Pao,A., Tang,M.-S. and Pfeifer,G.P. (1996) Preferential formation of benzo[a]pyrene adducts at lung cancer mutational hotspot in p53. Science, 274, 430-432.
49. Rundle,A., Tang,D., Hibshoosh,H., Estabrook,A., Schnabel,F., Cao,W., Grumet,S. Delia Rocca,A. and Perera,F. (2000) The relationship between genetic damage from polycyclic aromatic hydrocarbons in breast tissue and breast cancer. Carcinogenesis, 21, 1281-1289.
50. 32P-postlabeling, and GC/MS detection of 4-aminobiphenyl-DNA adducts in human peripheral lung in relation to metabolic activation pathways involving pulmonary N-oxidation, conjugation, and peroxidation. Mutat. Res., 378, 97-112.